LRRK2 and Parkinson disease: Recent research highlights promising targets such as striatal-enrichedprotein tyrosine phosphatase (STEP), PARP-1, MAO-B, GSK3β, and LRRK2, all of which are implicated in the pathogenesisof AD and PD.